Table 2.
Demographic characteristics of the participant sample.
| Hoarding Disorder (HD) |
Obsessive- Compulsive Disorder (OCD) |
Healthy Control (HC) |
Three group comparison |
HD vs. OCD comparison |
||||
|---|---|---|---|---|---|---|---|---|
| n = 15 | n = 17 | n = 25 | F / X2, p value |
t / X2, p value |
||||
| N | % | N | % | N | % | |||
| Gender | 1.99, 0.369 | 1.41, 0.234 | ||||||
| Female | 11 | 73.3 | 9 | 52.4 | 13 | 52.0 | ||
| Male | 4 | 26.7 | 8 | 47.6 | 12 | 48.0 | ||
| Ethnicity | 0.02, 0.989 | 0.02, 0.893 | ||||||
| Hispanic | 2 | 13.3 | 2 | 11.76 | 3 | 12.0 | ||
| Non-Hispanic | 13 | 86.7 | 15 | 88.24 | 22 | 88.0 | ||
| Race | 2.45, 0.295 | 0.41, 0.522 | ||||||
| Caucasian | 12 | 80.0 | 15 | 88.2 | 17 | 68.0 | ||
| Non-Caucasian | 3 | 20.0 | 2 | 11.2 | 8 | 32.0 | ||
| Psychotropic use | 6 | 40 | 11 | 64.7 | 31 | 12.0 | 12.56, 0.002 | 1.95, 0.162 |
| Antidepressants2 | 4 | 26.7 | 11 | 64.7 | 1 | 4.0 | 18.49, <0.001 | 4.63, 0.031 |
| Neuroleptics | 1 | 6.7 | 2 | 11.8 | 0 | 0.0 | 2.89, 0.236 | 0.24, 0.621 |
| Mood Stabilizers | 1 | 6.7 | 1 | 5.9 | 0 | 0.0 | 1.63, 0.442 | 0.01, 0.927 |
| Benzodiazapines/ Sedative Hypnotics |
5 | 33.3 | 2 | 11.8 | 1 | 4.0 | 6.79, 0.034 | 2.17, 0.141 |
| ADHD medications/ Stimulants |
1 | 6.7 | 1 | 5.9 | 1 | 4.0 | 0.15, 0.927 | 0.01, 0.927 |
| M | SD | M | SD | M | SD | |||
| Age, years | 54.1 | 15.2 | 36.1 | 10.4 | 44.8 | 16.2 | 6.18, 0.004 | −3.95, <0.001 |
| Education, years | 15.8 | 1.8 | 16.7 | 1.9 | 15.6 | 2.4 | 1.42, 0.306 | 1.36, 0.184 |
| CIR | 12.4 | 5.5 | 4.6 | 1.4 | 4.8 | 1.4 | 38.09, <0.001 | 6.92, <0.001 |
| UHSS | 26.7 | 4.1 | 6.6 | 3.6 | 3.4 | 2.6 | 54.50, <0.001 | 8.65, <0.001 |
| SI-R | 57.9 | 11.8 | 10.9 | 6.9 | 9.0 | 9.5 | 32.84, <0.001 | 8.86, <0.001 |
| YBOCS | 8.7 | 13.9 | 27.0 | 6.7 | 0.0 | 0.0 | 63.88, <0.001 | −5.14, <0.001 |
| BAI | 11.9 | 10.7 | 10.1 | 7.9 | 3.6 | 0.9 | 4.36, 0.018 | 0.38, 0.709 |
| BDI | 13.0 | 13.7 | 9.6 | 10.0 | 3.6 | 5.6 | 4.90, 0.012 | 0.58, 0.568 |
1
One HC subject was using buproprion for smoking cessation, one was using zaleplon as needed for sleep, and one was using amphetamine-dextroamphetamine for treatment of ADHD.
2
Antidepressant use consisted primarily of selective serotonin reuptake inhibitors (SSRIs), including citalopram, fluoxetine, fluvoxamine, and sertraline. One HD subject was taking buproprion and one was taking clomipramine; one OCD subject was taking buproprion and trazodone, one was taking an SSRI (fluoxetine) and buproprion, and one was taking an SSRI (citalopram) and trazodone; the remaining subjects were taking an SSRI antidepressant only.